Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis B: the disease.

S Sherlock1

  • 1Department of Surgery, Royal Free Hospital School of Medicine, London, UK.

Vaccine
|March 1, 1990
PubMed
Summary
This summary is machine-generated.

Hepatitis B virus (HBV) infection affects 300 million globally. Disease progression depends on acquisition route, host factors like sex and immunity, and geography, with vaccination impacting prevalence.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune cholangitis.

Clinics in liver disease·2001
Same author

A la carte interferon for hepatitis C?

Hepatology (Baltimore, Md.)·2000
Same author

The hepatic flaviviridae: summary.

Journal of viral hepatitis·2000
Same author

Biotechnologies and liver diseases.

Forum (Genoa, Italy)·1999
Same author

Carbon dioxide embolism following diagnostic hysteroscopy.

Anaesthesia and intensive care·1999
Same author

Focal nodular hyperplasia in a young female.

Journal of hepatology·1999
Same journal

Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study.

Vaccine·2026
Same journal

Safety and immunogenicity of a reduced, homologous booster dose of the BNT162b2 mRNA COVID-19 vaccine: a single blind, randomized, non-inferiority follow-up trial.

Vaccine·2026
Same journal

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026
Same journal

A historical overview of the anti-vaccine movement and its public health implications.

Vaccine·2026
Same journal

Vaccine strategies and development before and during the 1968 H3N2 influenza pandemic.

Vaccine·2026
Same journal

Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024.

Vaccine·2026
See all related articles

Area of Science:

  • Hepatology
  • Virology
  • Epidemiology

Background:

  • Hepatitis B virus (HBV) infection is a significant global health concern, affecting approximately 300 million individuals worldwide.
  • The natural history and clinical course of HBV infection are influenced by multiple factors, including the route and age of acquisition, host immunological status, sex, and geographic origin.

Purpose of the Study:

  • To discuss the variable natural history of Hepatitis B virus infection.
  • To review factors influencing disease progression and complications.
  • To present a recent classification system for chronic Hepatitis B surface antigen (HBsAg) carriers.

Main Methods:

  • Review of existing literature on Hepatitis B virus infection.
  • Analysis of factors affecting disease course.

Related Experiment Videos

  • Discussion of a new classification system for chronic carriers.

    • Main Results:

    • Disease progression is multifactorial, influenced by acquisition route (perinatal, childhood, drug abuse, healthcare exposure), sex, and immune status.
    • Geographic variations and changing lifestyles impact HBV prevalence.
    • Vaccination strategies are altering community prevalence rates.

    Conclusions:

    • Understanding the diverse natural history of HBV is crucial for patient management.
    • A comprehensive classification system aids in characterizing chronic HBV infection.
    • Public health interventions, including vaccination, are vital in controlling HBV spread.